Adipose-derived stem cells (ADSCs) are multipotent cells with a high capacity for self-renewal. They are ideal for regenerative therapy applications. ADSCs can differentiate into specialized cells of the body such as osteocytes; adipocytes; neural cells; vascular endothelial cells; cardiomyocytes; pancreatic beta-cells; and hepatocytes. Their easy accessibility in addition to low immunogenicity and their ability to secrete trophic factors as well as cytokines and chemokines make them the favorable cell type for experimental and clinical use. ADSCs are also demonstrated to have proangiogenic/immunomodulatory/anti-apoptotic/anti-inflammatory/anti-scarring effects. Many trials are underway to understand the potential of these cells to use for a wide range of clinical conditions including skeletal tissue repair; ischemic injuries; myocardial infarction; soft tissue regeneration and immune disorders.
These ADSCs were isolated from old adult female Sprague Dawley rat adipose tissue. The cells are passaged for purity then cryopreserved and delivered frozen. Each vial contains 1 x 106 cells in 1 mL volume. Cells are characterized by flow cytometry for CD90/CD105/CD44/CD29/CD45/CD34 and are negative for mycoplasma/yeast/fungi/bacteria. Cells are assured to further culture using the protocol provided.
Gender
Female
Growth Properties
Adherent
Quantity
1x106 cells / 1.0 ml
Morphology
Polygonal
Organism
R. norvegicus
Species
Rat
Propagation
Use of PriCoatTM T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) is required for cell adhesion to the culture vessels. PriGrow X Series Medium (TM5506) + 1% Penicillin/Streptomycin Solution (G255), 37.0°C, 5% CO?.